✦ LIBER ✦

Clinical pharmacokinetics of chlordiazepoxide in patients with alcoholic hepatitis

✍ Scribed by D. D. Morgan; J. D. Robinson; C. L. Mendenhall

Publisher: Springer
Year: 1981
Tongue: English
Weight: 733 KB
Volume: 19
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00562805

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of concomitant hep

Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease

✍ Tse-Ling Fong; Gary C. Kanel; Andrew Conrad; Boontar Valinluck; Francine Charbon 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

The significance of antibodies to hepatitis C virus in patients with chronic alcoholic liver disease is unclear. Prior studies have utilized the first-generation enzyme-linked immunosorbent assay, which is limited by problems with sensitivity and specificity. Hepatitis C virus infection in 137 pati

MELD accurately predicts mortality in pa

MELD accurately predicts mortality in patients with alcoholic hepatitis

✍ Winston Dunn; Laith H. Jamil; Larry S. Brown; Russell H. Wiesner; W. Ray Kim; K. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

Assessing severity of disease in patients with alcoholic hepatitis (AH) is useful for predicting mortality, guiding treatment decisions, and stratifying patients for therapeutic trials. The traditional disease-specific prognostic model used for this purpose is the Maddrey discriminant function (DF).

Relevance of anti-HCV reactivity in pati

Relevance of anti-HCV reactivity in patients with alcoholic hepatitis

✍ Mendenhall, C. L. ;Moritz, T. ;Chedid, A. ;Polito, A. J. ;Quan, S. ;Rouster, S. 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 450 KB

Pharmacokinetics of furosemide in patien

Pharmacokinetics of furosemide in patients with hepatic cirrhosis

✍ G. González; A. Arancibia; M. I. Rivas; P. Caro; C. Antezana 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 610 KB

Clinical pharmacokinetics of suramin in

Clinical pharmacokinetics of suramin in patients with onchocerciasis

✍ C. P. Chijioke; R. E. Umeh; A. U. Mbah; P. Nwonu; L. L. Fleckenstein; P. O. Okon 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 257 KB

Hepatitis cRNA quasispecies complexity i

Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease

✍ Kenneth E. Sherman; Susan D. Rouster; Charles Mendenhall; Donna Thee 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

Alcohol abuse is described as a major cofactor in the development of hepatitis C (HCV) associated liver disease and may play a role in the outcome of interferon-based treatment interventions. The association between HCV viral heterogeneity and alcohol has not been previously described. This study wa